e-HERO: Ending the HIV Epidemic in Rural Oklahoma
NCT05664802
Acquired Immunodeficiency Syndrome, Behavior
Flagstaff, Arizona, United States
View Trial DetailsNCT Number: NCT01119729
Human immunodeficiency virus (HIV) infection has been associated with a variety of cardiovascular diseases. Even most industrialised countries exhibit a growing and aging population of HIV-infected patients in the majority treated with antiretroviral drugs, the investigators still do not know much about the impact of cardiovascular diseases in this group of patients. The present study is an ongoing trial that was conducted as a prospective and multicentre survey, being schemed to analyse the frequency and clinical course of cardiac disorders in HIV-infected patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Department of Dermatology, University Hospital of Bochum, Bochum, North Rhine-Westphalia, Germany
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
● Acute cardiovascular disease or unstable hemodynamic status in the three weeks before inclusion
Prevalence of cardiovascular diseases including coronary artery disease, congestive heart failure, peripheral arterial disease, cerebrovascular events, and valvular diseases.
Prevalence of cardiovascular disorders determined by electrocardiography, exercise testing, echocardiography, blood samples.
University Hospital, Essen
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05664802
Acquired Immunodeficiency Syndrome, Behavior
Flagstaff, Arizona, United States
View Trial DetailsNCT05120869
Behavior, COVID-19
Las Cruces, New Mexico, United States
View Trial DetailsNCT06098690
Adherence, Patient, Behavior
El Paso, Texas, United States
View Trial DetailsNCT05242952
Behavior, Blood-Borne Infections
Orange, Connecticut, United States
View Trial Details